Lippoldt Darin
Chief Legal Officer
Lippoldt Darin has filed 7 SEC Form 4 filings (24 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.
On the most recent filing, Lippoldt Darin is listed as Chief Legal Officer at NEUROCRINE BIOSCIENCES INC. Inside the rolling window, Lippoldt Darin reported no open-market purchases and 4 open-market sales totaling $4.2M in NBIX. The largest disclosed transaction in the window is a sale of 10,000 NBIX shares on Jul 9, 2026, worth $1.8M.
Companies traded
Other insiders at NBIX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lippoldt Darin made?
Lippoldt Darin has filed 7 SEC Form 4 filings (24 transaction rows) across 1 company since 2025.
Which companies does Lippoldt Darin trade?
Lippoldt Darin has filed SEC Form 4 disclosures for 1 company, including NBIX.
When was Lippoldt Darin's most recent SEC Form 4 filing?
Lippoldt Darin's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.
What is Lippoldt Darin's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lippoldt Darin is listed as Chief Legal Officer.
What is Lippoldt Darin's total buy and sell value in the current window?
Inside the rolling retention window, Lippoldt Darin bought $0 and sold $4.2M based on SEC Form 4 filings.
What was Lippoldt Darin's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 NBIX shares on 2026-07-09, worth $1.8M, per SEC Form 4 filings.